| Human 3D vascularized organotypic microfluidic assays to study breast cancer cell extravasation JS Jeon, S Bersini, M Gilardi, G Dubini, JL Charest, M Moretti, RD Kamm Proceedings of the National Academy of Sciences 112 (1), 214-219, 2015 | 747 | 2015 |
| Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities CM Laumont, AC Banville, M Gilardi, DP Hollern, BH Nelson Nature Reviews Cancer 22 (7), 414-430, 2022 | 222 | 2022 |
| Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4 Z Wang, VH Wu, MM Allevato, M Gilardi, Y He, J Luis Callejas-Valera, ... Nature communications 10 (1), 5546, 2019 | 135 | 2019 |
| Tipifarnib as a Precision Therapy for HRAS-Mutant Head and Neck Squamous Cell Carcinomas M Gilardi, Z Wang, M Proietto, A Chillà, JL Calleja-Valera, Y Goto, ... Molecular cancer therapeutics 19 (9), 1784-1796, 2020 | 100 | 2020 |
| Human in vitro 3D co-culture model to engineer vascularized bone-mimicking tissues combining computational tools and statistical experimental approach S Bersini, M Gilardi, C Arrigoni, G Talò, M Zamai, L Zagra, V Caiolfa, ... Biomaterials 76, 157-172, 2016 | 85 | 2016 |
| HPV E2, E4, E5 drive alternative carcinogenic pathways in HPV positive cancers S Ren, DA Gaykalova, T Guo, AV Favorov, EJ Fertig, P Tamayo, ... Oncogene 39 (40), 6327-6339, 2020 | 78 | 2020 |
| 4E-BP1 is a tumor suppressor protein reactivated by mTOR inhibition in head and neck cancer Z Wang, X Feng, AA Molinolo, D Martin, L Vitale-Cross, N Nohata, M Ando, ... Cancer research 79 (7), 1438-1450, 2019 | 68 | 2019 |
| Engineering an environment for the study of fibrosis: a 3D human muscle model with endothelium specificity and endomysium S Bersini, M Gilardi, GS Ugolini, V Sansoni, G Talo, S Perego, S Zanotti, ... Cell reports 25 (13), 3858-3868. e4, 2018 | 68 | 2018 |
| Bioprinting and organ-on-chip applications towards personalized medicine for bone diseases C Arrigoni, M Gilardi, S Bersini, C Candrian, M Moretti Stem cell reviews and reports 13, 407-417, 2017 | 66 | 2017 |
| A 3D vascularized bone remodeling model combining osteoblasts and osteoclasts in a CaP nanoparticle-enriched matrix M Bongio, S Lopa, M Gilardi, S Bersini, M Moretti Nanomedicine 11 (9), 1073-1091, 2016 | 64 | 2016 |
| Cardiac Meets Skeletal: What's New in Microfluidic Models for Muscle Tissue Engineering MM Visone R, Gilardi M, Marsano A, Rasponi M, Bersini S Molecules, 2016 | 56 | 2016 |
| Disruption of the HER3-PI3K-mTOR oncogenic signaling axis and PD-1 blockade as a multimodal precision immunotherapy in head and neck cancer Z Wang, Y Goto, MM Allevato, VH Wu, R Saddawi-Konefka, M Gilardi, ... Nature communications 12 (1), 2383, 2021 | 50 | 2021 |
| In Vitro Co-Culture Models of Breast Cancer Metastatic Progression towards Bone. MM Arrigoni C, Bersini S, Gilardi M Int J Mol Sci., 2016 | 48 | 2016 |
| Tackling muscle fibrosis: From molecular mechanisms to next generation engineered models to predict drug delivery. MM Bersini S, Gilardi M, Mora M, Krol S, Arrigoni C, Candrian C, Zanotti S Adv Drug Deliv Rev, 2018 | 42 | 2018 |
| Erratum: Human 3D vascularized organotypic microfluidic assays to study breast cancer cell extravasation (Proc Natl Acad Sci USA (2015) 112: 1 JS Jeon, S Bersini, M Gilardi, G Dubini, JL Charest, M Moretti, RD Kamm Proceedings of the National Academy of Sciences of the United States of …, 2015 | 35 | 2015 |
| Muscarinic receptors promote castration-resistant growth of prostate cancer through a FAK–YAP signaling axis Y Goto, T Ando, H Izumi, X Feng, N Arang, M Gilardi, Z Wang, K Ando, ... Oncogene 39 (20), 4014-4027, 2020 | 33 | 2020 |
| Tumor heterogeneity: preclinical models, emerging technologies, and future applications M Proietto, M Crippa, C Damiani, V Pasquale, E Sacco, M Vanoni, ... Frontiers in Oncology 13, 1164535, 2023 | 32 | 2023 |
| Microneedle-mediated intratumoral delivery of anti-CTLA-4 promotes cDC1-dependent eradication of oral squamous cell carcinoma with limited irAEs M Gilardi, R Saddawi-Konefka, VH Wu, MA Lopez-Ramirez, Z Wang, ... Molecular cancer therapeutics 21 (4), 616-624, 2022 | 31 | 2022 |
| EGFR Regulates the Hippo pathway by promoting the tyrosine phosphorylation of MOB1 T Ando, N Arang, Z Wang, DE Costea, X Feng, Y Goto, H Izumi, M Gilardi, ... Communications Biology 4 (1), 1237, 2021 | 31 | 2021 |
| Direct but not indirect co-culture with osteogenically differentiated human bone marrow stromal cells increases RANKL/OPG ratio in human breast cancer cells generating bone … C Arrigoni, P De Luca, M Gilardi, S Previdi, M Broggini, M Moretti Molecular Cancer 13, 1-6, 2014 | 28 | 2014 |
matteo morettiRegenerative Medicine Technologies Lab, Ente Ospedaliero Cantonale, Lugano, CH在 eoc.ch 的电子邮件经过验证
